VRS
CRL icon

Virginia Retirement Systems’s Charles River Laboratories CRL Stock Holding History

Virginia Retirement Systems’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.86M Buy
17,000
+3,300
+24% +$588K 0.02% 373
2026
Q1 		$2.36M Buy
13,700
+500
+4% +$92.7K 0.02% 401
2025
Q4 		$2.63M Sell
13,200
-800
-6% -$145K 0.02% 367
2025
Q3 		$2.19M Buy
14,000
+1,500
+12% +$238K 0.01% 407
2025
Q2 		$1.9M Buy
12,500
+4,600
+58% +$613K 0.01% 416
2025
Q1 		$1.19M Buy
+7,900
New +$1.32M 0.01% 520
2021
Q2 		– Sell
-9,800
Closed -$2.84M – 1040
2021
Q1 		$2.84M Sell
9,800
-500
-5% -$139K 0.03% 364
2020
Q4 		$2.57M Buy
10,300
+1,300
+14% +$310K 0.03% 358
2020
Q3 		$2.04M Buy
9,000
+500
+6% +$104K 0.02% 370
2020
Q2 		$1.48M Sell
8,500
-6,300
-43% -$1.01M 0.02% 458
2020
Q1 		$1.87M Sell
14,800
-1,500
-9% -$225K 0.03% 396
2019
Q4 		$2.49M Buy
16,300
+1,400
+9% +$194K 0.03% 395
2019
Q3 		$1.97M Buy
14,900
+4,000
+37% +$536K 0.02% 435
2019
Q2 		$1.55M Hold
10,900
– – 0.02% 512
2019
Q1 		$1.58M Hold
10,900
– – 0.02% 505
2018
Q4 		$1.23M Buy
10,900
+2,600
+31% +$326K 0.02% 550
2018
Q3 		$1.12M Buy
8,300
+100
+1% +$12.3K 0.01% 676
2018
Q2 		$921K Buy
+8,200
New +$887K 0.01% 704
2018
Q1 		– Sell
-2,800
Closed -$306K – 998
2017
Q4 		$306K Sell
2,800
-17,200
-86% -$1.87M ﹤0.01% 891
2017
Q3 		$2.16M Sell
20,000
-4,100
-17% -$421K 0.03% 481
2017
Q2 		$2.44M Sell
24,100
-400
-2% -$36.8K 0.03% 424
2017
Q1 		$2.2M Buy
24,500
+16,100
+192% +$1.37M 0.03% 448
2016
Q4 		$640K Buy
8,400
+3,800
+83% +$289K 0.01% 691
2016
Q3 		$383K Buy
+4,600
New +$386K 0.01% 762

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Virginia Retirement Systems's CRL Position: Q2 2026 in Review

Virginia Retirement Systems increased its Charles River Laboratories (CRL) stake by 24% in Q2 2026, buying an estimated $588K and bringing the position to 17,000 shares worth $3.86M. The position accounts for 0.02% of the portfolio, ranked #373.

Virginia Retirement Systems first reported a position in CRL in Q3 2016 and has held it in 24 quarters since. 569 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Virginia Retirement Systems held 17,000 shares of Charles River Laboratories worth $3.86M as of Q2 2026.
  • Virginia Retirement Systems bought 3,300 Charles River Laboratories shares in Q2 2026, an estimated $588K.
  • Charles River Laboratories made up 0.02% of Virginia Retirement Systems's portfolio in Q2 2026, its #373 holding.
  • Virginia Retirement Systems first reported a position in Charles River Laboratories in Q3 2016 and has held it in 24 quarters since.
  • 569 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Virginia Retirement Systems's 13F filing for Q2 2026, filed 25 Aug 2026.